Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum CA 125 levels during the menstrual cycle.

P Lehtovirta1, D Apter, U H Stenman

  • 1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.

British Journal of Obstetrics and Gynaecology
|October 1, 1990
PubMed
Summary

Serum CA 125 levels rise during menstruation in all women. Premenstrual CA 125 elevation in anovulatory cycles suggests progesterone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2017
Same author

Stability of first trimester placental growth factor in serum and whole blood.

Prenatal diagnosis·2011
Same author

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

International journal of cancer·2011
Same author

Infrared interferometric analysis of thin films and optical surfaces.

Applied optics·2010
Same author

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

British journal of cancer·2009

Area of Science:

  • Gynecology and Reproductive Endocrinology
  • Clinical Biochemistry

Background:

  • Cancer antigen 125 (CA 125) is a tumor marker often monitored in gynecological oncology.
  • Fluctuations in CA 125 levels during the menstrual cycle can impact diagnostic accuracy.

Purpose of the Study:

  • To investigate the relationship between serum CA 125 levels and different phases of the menstrual cycle.
  • To explore the influence of ovulatory and anovulatory cycles on CA 125 concentrations.
  • To determine the correlation between CA 125 and progesterone levels in the premenstrual phase.

Main Methods:

  • Serum CA 125 concentrations were measured in women during various menstrual cycle phases.
  • Participants were categorized into groups with ovulatory and anovulatory cycles.
  • Statistical analysis was performed to assess correlations between CA 125, progesterone, and cycle type.

Main Results:

  • CA 125 levels were significantly elevated during menstruation in both ovulatory and anovulatory groups.
  • Premenstrual CA 125 elevation was observed in women with anovulatory cycles, but not ovulatory ones.
  • A negative correlation between serum CA 125 and progesterone was found in the premenstrual phase of anovulatory cycles.

Conclusions:

  • Premenstrual CA 125 elevation in anovulatory cycles may be linked to progesterone deficiency and premature endometrial vascular changes.
  • Progesterone's effect on CA 125 appears indirect, influencing endometrial control rather than direct synthesis.
  • Avoid CA 125 testing immediately before or during menstruation to prevent false-positive results in cancer diagnosis.

Related Experiment Videos